HCM
Highbridge Capital Management’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-166,234
| Closed | -$1.87M | – | 358 |
|
|
2023
Q4 | $1.87M | Sell |
166,234
-61,066
| -27% | -$686K | 0.08% | 80 |
|
|
2023
Q3 | $1.96M | Buy |
+227,300
| New | +$1.96M | 0.08% | 90 |
|
|
2023
Q2 | – | Sell |
-230,100
| Closed | -$2.5M | – | 440 |
|
|
2023
Q1 | $2.5M | Buy |
230,100
+43,800
| +24% | +$475K | 0.09% | 111 |
|
|
2022
Q4 | $2.09M | Sell |
186,300
-38,700
| -17% | -$434K | 0.06% | 206 |
|
|
2022
Q3 | $2.28M | Buy |
+225,000
| New | +$2.28M | 0.03% | 308 |
|
|
2021
Q3 | – | Sell |
-587,666
| Closed | -$8.53M | – | 330 |
|
|
2021
Q2 | $8.53M | Buy |
+587,666
| New | +$8.53M | 0.24% | 117 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1142 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1101 |
|
|
2016
Q1 | – | Sell |
-17,976
| Closed | -$295K | – | 1111 |
|
|
2015
Q4 | $295K | Buy |
+17,976
| New | +$295K | ﹤0.01% | 668 |
|
|
2015
Q2 | – | Sell |
-23,568
| Closed | -$409K | – | 1068 |
|
|
2015
Q1 | $409K | Sell |
23,568
-34,205
| -59% | -$594K | 0.01% | 612 |
|
|
2014
Q4 | $862K | Buy |
+57,773
| New | +$862K | 0.01% | 481 |
|